Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Burning Rock Biotech Limited stock logo
BNR
Burning Rock Biotech
$0.85
+3.6%
$0.77
$0.57
$3.25
$87.24M0.2358,375 shs10,189 shs
Desert Gold Ventures Inc. stock logo
DAU
Desert Gold Ventures
C$0.07
+16.7%
C$0.07
C$0.03
C$0.10
C$13.68M1.7170,192 shs12,000 shs
Peapack-Gladstone Financial Co. stock logo
PGC
Peapack-Gladstone Financial
$22.76
-0.5%
$23.68
$21.58
$31.49
$403.99M0.9984,038 shs35,167 shs
SBW
Western Asset Worldwide Income Fund
$10.86
$0.00
$8.86
$11.95
N/AN/A63,936 shsN/A
Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Burning Rock Biotech Limited stock logo
BNR
Burning Rock Biotech
-4.45%+7.66%+15.43%-11.74%-71.10%
Desert Gold Ventures Inc. stock logo
DAU
Desert Gold Ventures
-7.69%-14.29%-14.29%+71.43%+33.33%
Peapack-Gladstone Financial Co. stock logo
PGC
Peapack-Gladstone Financial
-8.63%-0.26%-2.26%-19.66%-12.30%
SBW
Western Asset Worldwide Income Fund
0.00%0.00%0.00%0.00%0.00%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Burning Rock Biotech Limited stock logo
BNR
Burning Rock Biotech
N/AN/AN/AN/AN/AN/AN/AN/A
Desert Gold Ventures Inc. stock logo
DAU
Desert Gold Ventures
N/AN/AN/AN/AN/AN/AN/AN/A
Peapack-Gladstone Financial Co. stock logo
PGC
Peapack-Gladstone Financial
3.9835 of 5 stars
3.32.01.70.01.62.53.8
SBW
Western Asset Worldwide Income Fund
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Burning Rock Biotech Limited stock logo
BNR
Burning Rock Biotech
N/AN/AN/AN/A
Desert Gold Ventures Inc. stock logo
DAU
Desert Gold Ventures
N/AN/AN/AN/A
Peapack-Gladstone Financial Co. stock logo
PGC
Peapack-Gladstone Financial
2.50
Moderate Buy$30.5034.01% Upside
SBW
Western Asset Worldwide Income Fund
N/AN/AN/AN/A

Current Analyst Ratings

Latest SBW, BNR, LCD, DAU, and PGC Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/24/2024
Peapack-Gladstone Financial Co. stock logo
PGC
Peapack-Gladstone Financial
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeOverweight ➝ Neutral
4/5/2024
Peapack-Gladstone Financial Co. stock logo
PGC
Peapack-Gladstone Financial
Keefe, Bruyette & Woods
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperform ➝ Outperform$33.50 ➝ $30.50
(Data available from 4/25/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Burning Rock Biotech Limited stock logo
BNR
Burning Rock Biotech
$75.70M1.15N/AN/A$1.05 per share0.81
Desert Gold Ventures Inc. stock logo
DAU
Desert Gold Ventures
N/AN/AC$0.00 per share60.00N/AN/A
Peapack-Gladstone Financial Co. stock logo
PGC
Peapack-Gladstone Financial
$377.59M1.07$3.45 per share6.59$32.76 per share0.69
SBW
Western Asset Worldwide Income Fund
N/AN/AN/AN/AN/AN/A

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Burning Rock Biotech Limited stock logo
BNR
Burning Rock Biotech
-$92.07M-$0.89N/AN/A-121.79%-71.77%-52.80%6/4/2024 (Estimated)
Desert Gold Ventures Inc. stock logo
DAU
Desert Gold Ventures
-C$1.27M-C$0.01N/AN/AN/A-3,951.95%-180.42%6/4/2024 (Estimated)
Peapack-Gladstone Financial Co. stock logo
PGC
Peapack-Gladstone Financial
$48.85M$2.1810.447.90N/A10.11%7.27%0.64%7/23/2024 (Estimated)
SBW
Western Asset Worldwide Income Fund
N/AN/A0.00N/AN/AN/AN/AN/A

Latest SBW, BNR, LCD, DAU, and PGC Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
3/28/2024Q4 2023
Burning Rock Biotech Limited stock logo
BNR
Burning Rock Biotech
N/A-$0.22-$0.22-$0.22N/A$17.05 million
1/25/2024Q4 2023
Peapack-Gladstone Financial Co. stock logo
PGC
Peapack-Gladstone Financial
$0.56$0.50-$0.06$0.52$54.91 million$54.27 million

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Burning Rock Biotech Limited stock logo
BNR
Burning Rock Biotech
N/AN/AN/AN/AN/A
Desert Gold Ventures Inc. stock logo
DAU
Desert Gold Ventures
N/AN/AN/AN/AN/A
Peapack-Gladstone Financial Co. stock logo
PGC
Peapack-Gladstone Financial
$0.200.88%N/A9.17%N/A
SBW
Western Asset Worldwide Income Fund
$0.878.01%N/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Burning Rock Biotech Limited stock logo
BNR
Burning Rock Biotech
N/A
3.36
3.09
Desert Gold Ventures Inc. stock logo
DAU
Desert Gold Ventures
124.81
2.39
0.54
Peapack-Gladstone Financial Co. stock logo
PGC
Peapack-Gladstone Financial
0.23
0.98
0.98
SBW
Western Asset Worldwide Income Fund
N/AN/AN/A

Ownership

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Burning Rock Biotech Limited stock logo
BNR
Burning Rock Biotech
1,138102.64 million71.54 millionNot Optionable
Desert Gold Ventures Inc. stock logo
DAU
Desert Gold Ventures
N/A195.47 millionN/ANot Optionable
Peapack-Gladstone Financial Co. stock logo
PGC
Peapack-Gladstone Financial
52117.75 million16.40 millionOptionable
SBW
Western Asset Worldwide Income Fund
N/AN/AN/ANot Optionable

SBW, BNR, LCD, DAU, and PGC Headlines

No headlines for this company have been tracked by MarketBeat.com

Media Sentiment Over Time

Company Descriptions

Burning Rock Biotech logo

Burning Rock Biotech

NASDAQ:BNR
Burning Rock Biotech Limited primarily develops and commercializes cancer therapy selection tests in the People's Republic of China. It operates in three segments: Central Laboratory Business, In-Hospital Business, and Pharma Research and Development Services. The company primarily offers next-generation sequencing-based tissue and liquid biopsy cancer therapy selection and prognosis prediction tests for various range of cancer types, including lung cancer, gastrointestinal cancer, prostate cancer, breast cancer, lymphomas, thyroid cancer, colorectal cancer, ovarian cancer, pancreatic cancer, and bladder cancer using tissue and liquid biopsy samples. Its principal products include OncoCompass IO, a corresponding test for liquid biopsy samples; OncoScreen IO, a pan-cancer test for tissue samples; and OncoCompass Target, a ctDNA liquid biopsy-based test for NSCLC. In addition, the company provides ColonCore for assessing microsatellite loci related to MSI status and detecting mutations in genes associated with gastrointestinal cancers; and brPROPHET, a pre-operative ctDNA detection and post-operative MRD calling for relapsed patients. Further, it has development and commercialization agreement with Myriad Genetics, Inc. to in-license Myriad myChoice tumor testing in China; licensing agreement with Oncocyte Corporation to in-license DetermaRx, a risk stratification test for early stage lung cancer patients in China; and collaborations on clinical trials and research studies with AstraZeneca, Bayer, Johnson & Johnson, CStone, BeiGene, Abbisko Therapeutics, and IMPACT Therapeutics and Merck KGaA. Additionally, the company offers OncoMaster, an automatic NGS data analysis and report interpretation machine for in-hospital model. Burning Rock Biotech Limited was incorporated in 2014 and is headquartered in Guangzhou, China.
Desert Gold Ventures logo

Desert Gold Ventures

CVE:DAU
Desert Gold Ventures Inc., an exploration stage company, engages in the acquisition, exploration, and development of mineral resource properties in Mali. The company primarily explores for gold ores. Its flagship project is the Senegal Mali Shear Zone project located in Western Mali. Desert Gold Ventures Inc. was incorporated in 2003 and is headquartered in Surrey, Canada.
Peapack-Gladstone Financial logo

Peapack-Gladstone Financial

NASDAQ:PGC
Peapack-Gladstone Financial Corporation operates as the bank holding company for Peapack-Gladstone Bank that provides private banking and wealth management services in the United States. The company operates in two segments, Banking and Peapack Private. It offers checking and savings accounts, money market and interest-bearing checking accounts, certificates of deposit, and individual retirement accounts. The company also provides working capital lines of credit, term loans for fixed asset acquisitions, commercial mortgages, multi-family mortgages, and other forms of asset-based financing services; and residential mortgages, home equity lines of credit, and other second mortgage loans. In addition, it offers corporate and industrial (C&I) and equipment finance, commercial real estate, multifamily, residential, and consumer lending activities; treasury management services; C&I advisory services; escrow management; deposit generation; investment management services; personal trust services, including services as executor, trustee, administrator, custodian, and guardian; and other financial planning, tax preparation, and advisory services. Further, the company provides telephone and Internet banking, merchant credit card, and customer support sales services. Its private banking clients include businesses, non-profits, and consumers; wealth management clients comprise individuals, families, foundations, endowments, trusts, and estates; and commercial loan clients include business owners, professionals, retailers, contractors, and real estate investors. The company operates its private banking locations in Bedminster, Morristown, Princeton, and Teaneck, New Jersey; and branches in Somerset, Morris, Hunterdon, and Union counties, as well as operates automated teller machines. Peapack-Gladstone Financial Corporation was founded in 1921 and is headquartered in Bedminster, New Jersey.

Western Asset Worldwide Income Fund

NYSE:SBW
Western Asset Worldwide Income Fund Inc. (the Fund) is a non-diversified, closed-end management investment fund. The Fund's investment objective is to maintain a high level of current income. The Fund seeks to maximize total return as its secondary objective. The Fund invests in securities and distributes dividends from net investment income and net realized gains. It also invests in high-yield and emerging market instruments that are subject to certain credit and market risks. The Fund's portfolio of investment includes Sovereign bonds, energy, financials, telecommunication services, building products, mining and metals, and materials. Legg Mason Partners Fund Advisor, LLC (LMPFA) is the investment manager of the Fund. Western Asset Management Company (Western Asset), Western Asset Management Company Limited (Western Asset Limited), Western Asset Management Company Pte. Ltd. (Western Singapore) and Western Asset Management Company Ltd. (Western Japan) are the Fund's sub advisers.